Target intelligence / Profile preview

Beta-mammal toxin Css2 (Css2) (Css2)

Target
Css2
Molecular classification
Scorpion venom toxin, Beta-mammal toxin, Sodium channel modulator
01

Overview

Beta-mammal toxin Css2 is a potent neurotoxin isolated from the venom of the Mexican scorpion Centruroides suffusus suffusus. It belongs to the beta-class of scorpion toxins, which are characterized by their ability to modulate the gating mechanism of voltage-gated sodium channels (Nav) by binding to neurotoxin receptor site 4 (UniProt P01490). This interaction causes the sodium channels to open at more hyperpolarized membrane potentials, leading to repetitive firing of action potentials and eventual paralysis (Possani et al., 2000). Clinically, Css2 is a primary driver of the severe systemic toxicity observed in scorpion stings, including life-threatening respiratory and cardiovascular complications. While not a traditional therapeutic target for drug development, it is the primary target for neutralization by polyvalent scorpion antivenoms such as Anascorp (FDA/NIH). Additionally, Css2 is utilized as a high-affinity ligand in research to study the structural biology and electrophysiology of sodium channel subunits. The toxin consists of 66 amino acids and is stabilized by four disulfide bridges, a structural motif common to many scorpion neurotoxins (Cohen et al., 2005). Its high specificity for mammalian sodium channels makes it particularly dangerous to humans but also a precise tool for pharmacological mapping.

Other names
CssIIToxin IICentruroides suffusus suffusus toxin 2Sodium channel modulatory toxin Css2
02

Mechanism of action

Css2 binds to neurotoxin receptor site 4 of voltage-gated sodium channels, shifting the activation threshold to more negative potentials and trapping the domain II voltage sensor in an activated state (UniProt P01490, Cohen et al., 2005).

03

Biological functions

Ion channel modulationNeurotransmission disruptionVoltage-gated sodium channel activation threshold shift
04

Disease associations

Scorpion envenomation
05

Safety considerations

Lethal neurotoxicityRespiratory failureCardiac arrhythmiaNeuromuscular hyperexcitability
06

Interacting drugs

Centruroides scorpion antivenom

2 more in the full profile.

Beyond the preview

Go deeper on Beta-mammal toxin Css2 (Css2) (Css2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-mammal toxin Css2 (Css2) (Css2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call